| RS2073621465 |
F8
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS2073628823 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2073629527 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2073630720 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2073632657 |
ASPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2073633067 |
ASPA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Spongy degeneration of central nervous system |
| RS2073645237 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS2073646176 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2073646633 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2073652081 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2073658 |
USF1
|
Health Risk |
risk factor |
Hyperlipidemia, familial combined |
| RS2073669074 |
ASPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Spongy degeneration of central nervous system, Abnormality of metabolism/homeostasis |
| RS2073701307 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS2073701678 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073702243 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073703461 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2073704298 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073708638 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073708846 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073709089 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073709795 |
PRPF31
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073711 |
CILP
|
Health Risk |
Benign; risk factor |
Lumbar disc disease, susceptibility to |
| RS2073715263 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Alport syndrome, Hematuria |
| RS2073718422 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2073745817 |
NBEA
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without early-onset generalized epilepsy, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2073752422 |
COL4A3
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS2073755958 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS2073763723 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS2073764726 |
F8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2073766224 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS2073779014 |
ASPA
|
Health Risk |
Pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2073793798 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS2073798309 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 11 |
| RS2073798559 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073800655 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073801044 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2073803030 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS2073817463 |
PRPF31
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073817965 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073818085 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 11 |
| RS2073818439 |
PRPF31;PRPF31-AS1
|
Health Risk |
Pathogenic |
— |
| RS2073842959 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2073854068 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073855020 |
PRPF31
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073856361 |
PRPF31
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS2073858956 |
SIN3A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2073859427 |
FHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2073860048 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2073864792 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2073866799 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, Thyroid cancer |
| RS2073871791 |
PRPF31
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073873693 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073873973 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2073875313 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073875700 |
PRPF31
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073876392 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073877472 |
ASPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS2073885767 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2073913069 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2073915687 |
FHL1
|
Health Risk |
Likely pathogenic |
Asymmetric septal hypertrophy, Asymmetric septal hypertrophy |
| RS2073916521 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS2073922219 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2073923152 |
SETBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2073923280 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2073926924 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS2073927340 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2073927586 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073929830 |
SETBP1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS2073958098 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Canavan Disease |
| RS2073961843 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 11 |
| RS2073961882 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2073962058 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073962186 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073964314 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073964376 |
FHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked myopathy with postural muscle atrophy, Cardiovascular phenotype |
| RS2073964950 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS2073970078 |
PRPF31
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073970450 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073970897 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073971805 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2073971858 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2073971890 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2073994731 |
KDM5C
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2073994786 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS2074020491 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2074021310 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2074026880 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2074027448 |
RPS19
|
Health Risk |
Pathogenic |
— |
| RS2074043162 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2074044055 |
MED25
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome |
| RS2074049374 |
MED25
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Inborn genetic diseases |
| RS2074057980 |
CIB2
|
Health Risk |
Pathogenic |
— |
| RS2074091750 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2074092203 |
KCNJ16
|
Health Risk |
Likely pathogenic |
Hypokalemic tubulopathy and deafness, Hypokalemic tubulopathy and deafness |
| RS2074094096 |
NDUFB7
|
Health Risk |
Likely pathogenic |
Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes, Mitochondrial complex I deficiency |
| RS2074096700 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2074097651 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS2074102664 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS2074117985 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2074118749 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |